Aspen HIV Prevention Pill Deal Expands African Access

Original Article by Tamar Kahn | Business Day | 27 July 2026

Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.

Image | Gam1983 | iStock/1181839849

Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt

Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.

Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.